Abstract:Alzheimer's disease (AD) is the most common neurodegenerative disorder with progressive memory and cognitive loss. Neuroinflammation is a central mechanism involved in the progression of AD. With the disruption of the blood-brain barrier (BBB), peripheral immune cells and inflammatory molecules enter into AD brain. However, the exact relationship between peripheral immune cells and AD remains unknown due to various challenges. This study aimed to investigate the potential causal association between peripheral immune cells and AD by using a two-sample Mendelian randomization (TSMR) analysis. We conducted a TSMR to decipher the causal relationship between AD and 731 types of peripheral immune cell parameters from the TBNK, regulatory T cell (Treg), myeloid cell, monocyte, maturation stages of T cell, dendritic cell (DC), and B cell panels. Various analytical methods were employed, including inverse variance weighting (IVW), MR Egger, and weighted median methods. The Cochran's Q statistic, MR-Egger intercept, and MR-PRESSO tests were used to verify the heterogeneity and horizontal pleiotropy of the results. To further verify our results, we also conducted a replication analysis. The analysis identified CD33 on CD14 + monocyte (OR = 1.03; 95% CI, 1.01–1.04; p = 1.14E−04; adjust- p = 0.042) had an increased risk association for AD, which was verified by the replication study. CD33 on CD33dim HLA DR + CD11b- cell (OR = 1.02; 95% CI, 1.01–1.04; p = 2.87E−04; adjust- p = 0.035) had an increased risk association for AD, while secreting CD4 regulatory T cell %CD4 regulatory T cell (OR = 0.97; 95% CI, 0.96–0.99; p = 1.90E−04; adjust- p = 0.046) and CD25 on switched memory B cell (OR = 0.95; 95% CI, 0.92–0.98; p = 2.87E−04; adjust- p = 0.042) were discovered to be related to a lower risk of AD. However, the causal effect of these three immune cells on AD was insufficiently validated in the replication analysis. The MR analysis suggests a potential causal relationship between peripheral immune cells and the risk of AD. Further extensive research is needed on the specific role of peripheral immune cells in AD.

The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells

T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease

The role of the immune system in Alzheimer's disease

The role of the immune system in Alzheimer’s disease

Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease

Neuroimmune Mechanisms Underlying Alzheimer's disease: Insights into central and peripheral immune cell crosstalk

Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer's Disease: Are Immunotherapies Effective or Off-Target?

Peripheral Immune Cells Contribute to the Pathogenesis of Alzheimer's Disease

Immune attack: the role of inflammation in Alzheimer disease

Alzheimer's Disease: From Immune Homeostasis to Neuroinflammatory Condition

Periphery and brain, innate and adaptive immunity in Parkinson's disease

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets

Neuroinflammation and Neuroimmunology in Alzheimer's disease: The role of T‐lymphocytes in Alzheimer's disease

Role of Pro-Inflammatory Cytokines Released from Microglia in Alzheimer's Disease.

Role Of Pro-Inflammatory Cytokines Released From Microglia In Alzheimer'S Disease

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention

The neuroimmune axis of Alzheimer's disease

The Role of T Cells in the Pathogenesis of Parkinson's Disease

The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function